Johnson & Johnson submits its single-dose COVID-19 vaccine for FDA emergency use authorization | The Peru Gazette

News Categories

Site search

More About The Peru Gazette

The editor is John Ryan at email: perugazette@gmail.com. The Peru Gazette is a free community, education and information website. It is non-commercial and does not accept paid advertising.

Comment Policy

The Peru Gazette welcomes comments on posted stories. The author MUST include his/her first and last name. No foul or libelous language permitted. The Peru Gazette reserves the right to not publish a comment.

Recent Comments

Jim Mason on A. Mason descendants witness historic painting reproduction being put in place at Heyworth/Mason Park
Joe Potosky on NY plans to change the way you heat your home. Gas, oil, propane furnaces to be phased out
Joe Potosky on NY Thruway plans toll hike: How much more will you pay?
Joe Potosky on Help Wanted: Businesses still scramble for employees, legislators ponder solutions
T Goheens on NY Regents debate worth of exams for high school graduation
Joe Potosky on NY Regents debate worth of exams for high school graduation
Joe Potosky on Should NY spend $4.2 billion on climate change mitigation and the environment?
Ryanj on St. Augustine’s Soup Kitchen Menu for Wednesday, October 26, 2022

Johnson & Johnson submits its single-dose COVID-19 vaccine for FDA emergency use authorization

Source: Johnson & Johnson submits its single-dose COVID-19 vaccine for FDA emergency use authorization

Posted: February 5th, 2021 under Heathcare News.